Ambulatory urodynamics in clinical practice: A single centre experience

2019 ◽  
Vol 38 (8) ◽  
pp. 2077-2082 ◽  
Author(s):  
Hector Cantu ◽  
Ala'a Sharaf ◽  
Wendy Bevan ◽  
Anna Hassine ◽  
Hashim Hashim
Keyword(s):  
Clinical Practice ◽  
Single Centre ◽  
Single Centre Experience ◽  
Ambulatory Urodynamics

387 Ambulatory urodynamics in clinical practice: A single centre experience

2014 ◽  
Vol 13 (1) ◽  
pp. e387 ◽  
Author(s):  
J.P. Williams ◽  
W. Bevan ◽  
J. Ellis-Jones ◽  
H. Hashim
Keyword(s):  
Clinical Practice ◽  
Single Centre ◽  
Single Centre Experience ◽  
Ambulatory Urodynamics

P.08.4 INCIDENCE AND MANAGEMENT OF ACHALASIA IN CLINICAL PRACTICE: AN EIGHT-YEAR SINGLE CENTRE EXPERIENCE

2016 ◽  
Vol 48 ◽  
pp. e166
Author(s):  
A. Michielan ◽  
G. Betetto ◽  
F. Lamboglia ◽  
R. Cappuccio ◽  
F.N. Bortoluzzi ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Single Centre ◽  
Single Centre Experience

scholarly journals Efficacy of Liraglutide in clinical practice: Single centre experience

2020 ◽  
Vol 36 (3) ◽  
Author(s):  
Muhammad Owais Rashid ◽  
Sumerah Jabeen ◽  
Adeel Khoja ◽  
Najmul Islam
Keyword(s):  
Clinical Practice ◽  
Clinical Judgment ◽  
University Hospital ◽  
Published Data ◽  
Single Centre ◽  
Dipeptidyl Peptidase 4 ◽  
Creative Commons ◽  
Single Centre Experience ◽  
Type Two Diabetes ◽  
Diabetes Patients

Background and Objective: GLP-one receptor agonists are amongst the unique antidiabetes medications that have significant metabolic and cardiovascular benefits in addition to glucose lowering effect. To best of our knowledge, there is no published data on efficacy of liraglutide use among Pakistani population.Our objective was to ascertain the efficacy of liraglutide use among type two diabetes patients. Methods: This retrospective study was conducted at the Endocrinology Clinics of Aga Khan University Hospital (AKUH) Karachi, Pakistan during the period from July 01, 2016 to 30th June, 2017. Liraglutide was prescribed to 68 obese type two diabetes patients with uncontrolled diabetes taking more than one oral medication ± insulin. Starting dose of Liraglutide was 0.6 mg, which was increased to 1.2 mg after 1-2 weeks with further increment to 1.8 mg/day based on tolerance and individual patient preference. Dose of other diabetes medications was adjusted according to clinical judgment whereas Dipeptidyl peptidase-4 (DPP-4) inhibitors were discontinued. Results: Mean age of cohort was 55 years (SD=10.94 years) with median body mass index of 36.45 kg/m2 and majority (57.35%) were on a dose of 1.2 mg of Liraglutide per day. Median HbA1c reduced to 7.50% and 7.40% at three months and six months respectively vs 8.45% at baseline. Mean reduction in weight after three month was two kilograms and at six months, it was 1.38 kilograms respectively. Conclusion: Liraglutide as add on therapy demonstrated favourable HbA1c and weight reduction in obese uncontrolled type two Diabetes Pakistani subjects. doi: https://doi.org/10.12669/pjms.36.3.358 How to cite this:Rashid MO, Jabeen S, Khoja A, Islam N. Efficacy of Liraglutide in clinical practice: Single centre experience. Pak J Med Sci. 2020;36(3):---------. doi: https://doi.org/10.12669/pjms.36.3.358 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

scholarly journals Dobutamine stress cardiovascular MR in clinical practice: a single centre experience

2011 ◽  
Vol 13 (S1) ◽  
Author(s):  
SK Khambekar ◽  
M Byrant ◽  
JS Shambrook ◽  
CP Peebles ◽  
IW Brown ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Dobutamine Stress ◽  
Single Centre ◽  
Cardiovascular Mr ◽  
Single Centre Experience

scholarly journals Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience

2017 ◽  
Vol 25 (11) ◽  
pp. 611-617
Author(s):  
W. S. Remkes ◽  
R. S. Hermanides ◽  
M. W. Kennedy ◽  
E. Fabris ◽  
E. Kaplan ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Daily Clinical Practice ◽  
Single Centre ◽  
Bioresorbable Vascular Scaffold ◽  
Single Centre Experience ◽  
Vascular Scaffold
Sign in / Sign up

Export Citation Format

Share Document